Related Experiment Video
Updated: May 3, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
Optimal management of primary retroperitoneal sarcoma: an update
Aisha B Miah1, Jonathan Hannay, Charlotte Benson
1Sarcoma Multidisciplinary Team, Royal Marsden Hospital, London, UK.
Expert Review of Anticancer Therapy
|February 15, 2014
Summary
Retroperitoneal sarcomas are rare cancers requiring surgical removal. Complete resection is challenging due to location, and recurrence is common, necessitating further research into multimodality treatments.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Soft tissue sarcomas are diverse cancers with over 50 subtypes.
- Retroperitoneal sarcomas constitute 10-15% of soft tissue sarcomas.
- Surgery is the primary curative treatment for sarcomas.
Purpose of the Study:
- To review initial investigations, prognostic factors, and surgical management of retroperitoneal sarcomas.
- To discuss current evidence and research on multimodality treatment for these tumors.
Main Methods:
- Review of existing literature and research on retroperitoneal sarcomas.
- Analysis of surgical challenges, recurrence rates, and treatment outcomes.
Main Results:
- Surgery for retroperitoneal sarcomas is complex due to anatomical location and proximity to vital structures.
- Achieving wide surgical margins can be difficult, leading to high rates of local recurrence.
- Local recurrence remains a significant cause of mortality even after complete resection.
Conclusions:
- Optimal surgical management is crucial for improving outcomes in retroperitoneal sarcoma patients.
- Further investigation into multimodality treatment strategies is warranted to improve local control and survival rates.
